{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T19:23:39Z","timestamp":1793129019165,"version":"4.5.0"},"reference-count":240,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.neuropharm.2022.109371","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:45:28Z","timestamp":1670546728000},"page":"109371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Purinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer's disease"],"prefix":"10.1016","volume":"226","author":[{"given":"Deidiane Elisa","family":"Ribeiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyvia Lintzmaier","family":"Petiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talita","family":"Glaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1gatha","family":"Oliveira-Giacomelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Andrejew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando de Azevedo Ribeiro","family":"Saab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena da Silva","family":"Milanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrique Correia","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa Fernandes Arnaud","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"La Banca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz Monteiro","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiana","family":"Lameu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Ribeiro","family":"Resende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio T.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.neuropharm.2022.109371_bib1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1750-3639.2007.00112.x","article-title":"Up-regulation of adenosine receptors in the frontal cortex in Alzheimer's disease","volume":"18","author":"Albasanz","year":"2008","journal-title":"Brain Pathol."},{"issue":"4","key":"10.1016\/j.neuropharm.2022.109371_bib2","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1750-3639.2003.tb00475.x","article-title":"A1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation","volume":"13","author":"Angulo","year":"2003","journal-title":"Brain Pathol."},{"issue":"12","key":"10.1016\/j.neuropharm.2022.109371_bib3","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.febslet.2014.04.048","article-title":"Identification of P2X2\/P2X4\/P2X6 heterotrimeric receptors using atomic force microscopy (AFM) imaging","volume":"588","author":"Antonio","year":"2014","journal-title":"FEBS Lett."},{"issue":"7","key":"10.1016\/j.neuropharm.2022.109371_bib4","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.3390\/cells9071595","article-title":"Microglia purinoceptor P2Y6: an emerging therapeutic target in CNS diseases","volume":"9","author":"Anwar","year":"2020","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.neuropharm.2022.109371_bib5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/14728222.2020.1738391","article-title":"Alzheimer's disease: microglia targets and their modulation to promote amyloid phagocytosis and mitigate neuroinflammation","volume":"24","author":"Anwar","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109371_bib6","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1742-4658.2008.06796.x","article-title":"Membrane compartments and purinergic signalling: P2X receptors in neurodegenerative and neuroinflammatory events","volume":"276","author":"Apolloni","year":"2009","journal-title":"FEBS J."},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109371_bib7","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3233\/JAD-2009-1087","article-title":"Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer's disease mice","volume":"17","author":"Arendash","year":"2009","journal-title":"J.\u00a0Alzheim. Dis."},{"issue":"4","key":"10.1016\/j.neuropharm.2022.109371_bib8","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.neuroscience.2006.07.021","article-title":"Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production","volume":"142","author":"Arendash","year":"2006","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109371_bib9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.5114\/fn.2019.85929","article-title":"Risk factors for Alzheimer's disease","volume":"57","author":"Armstrong","year":"2019","journal-title":"Folia Neuropathol."},{"issue":"7","key":"10.1016\/j.neuropharm.2022.109371_bib10","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1517\/13543784.2011.578068","article-title":"A\u00a0potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases","volume":"20","author":"Arulkumaran","year":"2011","journal-title":"Expet Opin. Invest. Drugs"},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109371_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121419","article-title":"Renal intercalated cells sense and mediate inflammation via the P2Y14 receptor","volume":"10","author":"Azroyan","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109371_bib12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/039463200601900207","article-title":"P2Y2 receptor up-regulation induced by guanosine or UTP in rat brain cultured astrocytes","volume":"19","author":"Ballerini","year":"2006","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109371_bib13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00406-017-0817-7","article-title":"Antioxidant uric acid in treated and untreated subjects with major depressive disorder: a meta-analysis and meta-regression","volume":"268","author":"Bartoli","year":"2018","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109371_bib14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.bbr.2008.10.018","article-title":"Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: relevance for neuropsychiatric disorders","volume":"198","author":"Basso","year":"2009","journal-title":"Behav. Brain Res."},{"issue":"18","key":"10.1016\/j.neuropharm.2022.109371_bib15","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1097\/WNR.0b013e3282f262f6","article-title":"Sleep deprivation upregulates A1 adenosine receptors in the rat basal forebrain","volume":"18","author":"Basheer","year":"2007","journal-title":"Neuroreport"},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109371_bib16","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/mp.2012.8","article-title":"Adenosine A(2A) receptor blockade reverts hippocampal stress-induced deficits and restores corticosterone circadian oscillation","volume":"18","author":"Batalha","year":"2013","journal-title":"Mol. Psychiatr."},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109371_bib17","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1471-4159.2006.04101.x","article-title":"A\u00a0role for P2X7 in microglial proliferation","volume":"99","author":"Bianco","year":"2006","journal-title":"J.\u00a0Neurochem."},{"issue":"5","key":"10.1016\/j.neuropharm.2022.109371_bib18","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.5114\/aoms.2017.68943","article-title":"Neuropsychiatric symptoms and faster progression of cognitive impairments as predictors of risk of conversion of mild cognitive impairment to dementia","volume":"13","author":"Bidzan","year":"2017","journal-title":"Arch. Med. Sci."},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109371_bib19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/glia.22422","article-title":"The Importance of astrocyte-derived purines in the modulation of sleep","volume":"61","author":"Blutstein","year":"2013","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109371_bib20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1055\/s-2007-1017069","article-title":"The S-deficiency hypothesis of depression and the two-process model of sleep regulation","volume":"20","author":"Borb\u00e9ly","year":"1987","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.neuropharm.2022.109371_bib21","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neuroscience.2011.05.049","article-title":"Resilience and reduced c-Fos expression in P2X7 receptor knockout mice exposed to repeated forced swim test","volume":"189","author":"Boucher","year":"2011","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109371_bib22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/jcbfm.2012.169","article-title":"Purinergic receptors regulate myogenic tone in cerebral parenchymal arterioles","volume":"33","author":"Brayden","year":"2013","journal-title":"J.\u00a0Cerebr. Blood Flow Metabol.: official journal of the International Society of Cerebral Blood Flow and Metabolism"},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109371_bib23","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1006\/mcne.2001.1054","article-title":"Purinergic (P2X7) receptor activation of microglia induces cell death via an interleukin-1-independent mechanism","volume":"19","author":"Brough","year":"2002","journal-title":"Molecular and cellular neurosciences"},{"key":"10.1016\/j.neuropharm.2022.109371_bib24","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3389\/fnins.2018.00330","article-title":"Sleep disorders associated with Alzheimer's disease: a perspective","volume":"12","author":"Brzecka","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109371_bib25","doi-asserted-by":"crossref","DOI":"10.1177\/2398212818817494","article-title":"Purine and purinergic receptors","volume":"2","author":"Burnstock","year":"2018","journal-title":"Brain and neuroscience advances"},{"key":"10.1016\/j.neuropharm.2022.109371_bib26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11302-015-9452-9","article-title":"Purinergic signalling during development and ageing","volume":"11","author":"Burnstock","year":"2015","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.neuropharm.2022.109371_bib27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/B978-0-12-385526-8.00011-4","article-title":"P2X receptors in health and disease","volume":"61","author":"Burnstock","year":"2011","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109371_bib28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0074-7696(04)40002-3","article-title":"Cellular distribution and functions of P2 receptor subtypes in different systems","volume":"240","author":"Burnstock","year":"2004","journal-title":"Int. Rev. Cytol."},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109371_bib29","first-page":"116","article-title":"Purinergic signaling","volume":"1","author":"Burnstock","year":"2012","journal-title":"Wiley Interdisciplinary Reviews: Membrane Transport and Signaling"},{"issue":"47","key":"10.1016\/j.neuropharm.2022.109371_bib30","doi-asserted-by":"crossref","first-page":"14741","DOI":"10.1523\/JNEUROSCI.3728-09.2009","article-title":"Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway","volume":"29","author":"Canas","year":"2009","journal-title":"J.\u00a0Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109371_bib31","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3233\/JAD-2009-1071","article-title":"Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic mice","volume":"17","author":"Cao","year":"2009","journal-title":"J.\u00a0Alzheim. Dis."},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109371_bib32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nri.2016.4","article-title":"Purinergic regulation of the immune system","volume":"16","author":"Cekic","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109371_bib33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jalz.2015.03.004","article-title":"Sleep duration, cognitive decline, and dementia risk in older women","volume":"12","author":"Chen","year":"2016","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.neuropharm.2022.109371_bib34","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neuroscience.2014.08.036","article-title":"Brilliant Blue G improves cognition in an animal model of Alzheimer's disease and inhibits amyloid-\u03b2-induced loss of filopodia and dendrite spines in hippocampal neurons","volume":"279","author":"Chen","year":"2014","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109371_bib35","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0304-3940(00)00961-7","article-title":"Decrease of adenosine A-1 receptor gene expression in cerebral cortex of aged rats","volume":"283","author":"Cheng","year":"2000","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109371_bib36","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.foodchem.2012.04.148","article-title":"Crude caffeine reduces memory impairment and amyloid \u03b2(1-42) levels in an Alzheimer's mouse model","volume":"135","author":"Chu","year":"2012","journal-title":"Food Chem."},{"issue":"4","key":"10.1016\/j.neuropharm.2022.109371_bib37","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11302-018-9629-0","article-title":"Role of purinergic receptors in the Alzheimer's disease","volume":"14","author":"Cie\u015blak","year":"2018","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.neuropharm.2022.109371_bib38","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3389\/fpsyt.2014.00067","article-title":"Overexpression of adenosine A2A receptors in rats: effects on depression, locomotion, and anxiety","volume":"5","author":"Coelho","year":"2014","journal-title":"Front. Psychiatr."},{"issue":"9","key":"10.1016\/j.neuropharm.2022.109371_bib39","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0028-3908(97)00140-8","article-title":"Tissue distribution of the P2X7 receptor","volume":"36","author":"Collo","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109371_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114347","article-title":"P2Y4, P2Y6 and P2Y11 receptors: from the early days of cloning to their function","volume":"187","author":"Communi","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109371_bib41","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.yebeh.2018.06.048","article-title":"Early-life hyperthermic seizures upregulate adenosine A2A receptors in the cortex and promote depressive-like behavior in adult rats","volume":"86","author":"Crespo","year":"2018","journal-title":"Epilepsy Behav."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109371_bib42","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1017\/S1461145711001933","article-title":"The absence of P2X7 receptors (P2rx7) on non-haematopoietic cells leads to selective alteration in mood-related behaviour with dysregulated gene expression and stress reactivity in mice","volume":"16","author":"Cs\u00f6lle","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"6","key":"10.1016\/j.neuropharm.2022.109371_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066547","article-title":"Neurochemical changes in the mouse Hippocampus underlying the antidepressant effect of genetic deletion of P2X7 receptors","volume":"8","author":"Cs\u00f6lle","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.neuropharm.2022.109371_bib44","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.neuroscience.2006.05.024","article-title":"Increased density and synapto-protective effect of adenosine A2A receptors upon sub-chronic restraint stress","volume":"141","author":"Cunha","year":"2006","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109371_bib45","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1046\/j.1471-4159.2001.00095.x","article-title":"Parallel modification of adenosine extracellular metabolism and modulatory action in the hippocampus of aged rats","volume":"76","author":"Cunha","year":"2001","journal-title":"J.\u00a0Neurochem."},{"issue":"11","key":"10.1016\/j.neuropharm.2022.109371_bib46","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/00001756-199507310-00029","article-title":"Modification of A1 and A2a adenosine receptor binding in aged striatum, hippocampus and cortex of the rat","volume":"6","author":"Cunha","year":"1995","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2022.109371_bib47","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1046\/j.1432-1327.2001.02183.x","article-title":"Age-dependent decrease in adenosine A1 receptor binding sites in the rat brain. Effect of cis unsaturated free fatty acids","volume":"268","author":"Cunha","year":"2001","journal-title":"Eur. J. Biochem."},{"issue":"4","key":"10.1016\/j.neuropharm.2022.109371_bib48","first-page":"506","article-title":"Receptory nukleotydowe w uczeniu i plastyczno\u015bci neuronalnej [Nucleotide receptors in learning and neuronal plasticity]","volume":"60","author":"Czajkowski","year":"2014","journal-title":"Postepy Biochem."},{"key":"10.1016\/j.neuropharm.2022.109371_bib49","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/7854_2014_363","article-title":"Sleep deprivation therapy for depression","volume":"25","author":"Dallaspezia","year":"2015","journal-title":"Current topics in behavioral neurosciences"},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109371_bib51","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/039463200702000210","article-title":"Activation of P2X(7) receptors stimulates the expression of P2Y(2) receptor mRNA in astrocytes cultured from rat brain","volume":"20","author":"D'Alimonte","year":"2007","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109371_bib52","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/204649","article-title":"S-Adenosyl-L-Methionine augmentation in patients with stage II treatment-resistant major depressive disorder: an open label, fixed dose, single-blind study","volume":"2013","author":"De Berardis","year":"2013","journal-title":"Sci. World J."},{"issue":"4","key":"10.1016\/j.neuropharm.2022.109371_bib53","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41583-022-00558-9","article-title":"Impaired insulin signalling and allostatic load in Alzheimer disease","volume":"23","author":"De Felice","year":"2022","journal-title":"Nat. Rev. Neurosci."},{"issue":"Pt 1","key":"10.1016\/j.neuropharm.2022.109371_bib54","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1242\/jcs.091736","article-title":"Adenylate cyclase 5 coordinates the action of ADP, P2Y1, P2Y13 and ATP-gated P2X7 receptors on axonal elongation","volume":"125","author":"Del Puerto","year":"2012","journal-title":"J.\u00a0Cell Sci."},{"issue":"4","key":"10.1016\/j.neuropharm.2022.109371_bib55","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1074\/jbc.M110.200618","article-title":"The purinergic receptor P2X7 triggers alpha-secretase-dependent processing of the amyloid precursor protein","volume":"286","author":"Delarasse","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2022.109371_bib56","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1038\/ncomms6422","article-title":"Metabotropic P2Y1 receptor signalling mediates astrocytic hyperactivity in\u00a0vivo in an Alzheimer's disease mouse model","volume":"5","author":"Delekate","year":"2014","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.neuropharm.2022.109371_bib57","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1007\/s11064-016-1950-9","article-title":"Resveratrol attenuates A\u03b225-35 caused neurotoxicity by inducing Autophagy through the TyrRS-PARP1-SIRT1 signaling pathway","volume":"41","author":"Deng","year":"2016","journal-title":"Neurochem. Res."},{"issue":"18","key":"10.1016\/j.neuropharm.2022.109371_bib58","doi-asserted-by":"crossref","first-page":"7143","DOI":"10.1523\/JNEUROSCI.21-18-07143.2001","article-title":"Neuronal P2X7 receptors are targeted to presynaptic terminals in the central and peripheral nervous systems","volume":"21","author":"Deuchars","year":"2001","journal-title":"J.\u00a0Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109371_bib59","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.immuni.2017.06.020","article-title":"The P2X7 receptor in infection and inflammation","volume":"47","author":"Di Virgilio","year":"2017","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109371_bib60","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3233\/JAD-2012-111979","article-title":"A\u03b225-35 injection into the temporal cortex induces chronic inflammation that contributes to neurodegeneration and spatial memory impairment in rats","volume":"30","author":"Diaz","year":"2012","journal-title":"J.\u00a0Alzheim. Dis."},{"issue":"8","key":"10.1016\/j.neuropharm.2022.109371_bib61","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.neurobiolaging.2011.09.040","article-title":"In\u00a0vivo P2X7 inhibition reduces amyloid plaques in Alzheimer's disease through GSK3\u03b2 and secretases","volume":"33","author":"Diaz-Hernandez","year":"2012","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.neuropharm.2022.109371_bib62","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2174\/187152410793429692","article-title":"Purine molecules as hypnogenic factors role of adenosine, ATP, and caffeine","volume":"10","author":"D\u00edaz-Mu\u00f1oz","year":"2010","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"10.1016\/j.neuropharm.2022.109371_bib63","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.brainres.2017.09.011","article-title":"Monoamine involvement in the antidepressant-like effect induced by P2 blockade","volume":"1676","author":"Diniz","year":"2017","journal-title":"Brain Res."},{"issue":"32","key":"10.1016\/j.neuropharm.2022.109371_bib64","doi-asserted-by":"crossref","first-page":"10511","DOI":"10.1523\/JNEUROSCI.0405-14.2014","article-title":"Activation of neuronal NMDA receptors triggers transient ATP-mediated microglial process outgrowth","volume":"34","author":"Dissing-Olesen","year":"2014","journal-title":"J.\u00a0Neurosci."},{"issue":"4","key":"10.1016\/j.neuropharm.2022.109371_bib65","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/glia.20048","article-title":"Activation of P2 nucleotide receptors stimulates acid efflux from astrocytes","volume":"47","author":"Dixon","year":"2004","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2022.109371_bib66","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3389\/fimmu.2018.01159","article-title":"Human P2Y11 expression level affects human P2X7 receptor-mediated cell death","volume":"9","author":"Dreisig","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109371_bib67","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3233\/JAD-180688","article-title":"Neuropathologic correlates of psychiatric symptoms in Alzheimer's disease","volume":"66","author":"Ehrenberg","year":"2018","journal-title":"J.\u00a0Alzheim. Dis."},{"issue":"11Suppl.\u00a06","key":"10.1016\/j.neuropharm.2022.109371_bib68","first-page":"S82","article-title":"Adenosine A2A receptors and depression","volume":"61","author":"El Yacoubi","year":"2003","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109371_bib69","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/sj.bjp.0704240","article-title":"Adenosine A2A receptor antagonists are potential antidepressants: evidence based on pharmacology and A2A receptor knockout mice","volume":"134","author":"El Yacoubi","year":"2001","journal-title":"Br. J. Pharmacol."},{"issue":"16","key":"10.1016\/j.neuropharm.2022.109371_bib70","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1073\/pnas.1614677114","article-title":"Recovery sleep after extended wakefulness restores elevated A1 adenosine receptor availability in the human brain","volume":"114","author":"Elmenhorst","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"9","key":"10.1016\/j.neuropharm.2022.109371_bib71","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1523\/JNEUROSCI.5066-06.2007","article-title":"Sleep deprivation increases A1 adenosine receptor binding in the human brain: a positron emission tomography study","volume":"27","author":"Elmenhorst","year":"2007","journal-title":"J.\u00a0Neurosci."},{"issue":"6","key":"10.1016\/j.neuropharm.2022.109371_bib72","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/wmts.62","article-title":"Coupling of P2Y receptors to G proteins and other signaling pathways","volume":"1","author":"Erb","year":"2012","journal-title":"Wiley interdisciplinary reviews. Membrane transport and signaling"},{"key":"10.1016\/j.neuropharm.2022.109371_bib73","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.brainresbull.2018.10.014","article-title":"Purinergic signaling in Alzheimer's disease","volume":"151","author":"Erb","year":"2019","journal-title":"Brain Res. Bull."},{"issue":"4","key":"10.1016\/j.neuropharm.2022.109371_bib74","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.celrep.2018.04.001","article-title":"P2Y12R-Dependent translocation mechanisms gate the changing microglial landscape","volume":"23","author":"Eyo","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2022.109371_bib75","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3389\/fnmol.2018.00235","article-title":"Beneficial effect of a selective adenosine A2A receptor antagonist in the APPswe\/PS1dE9 mouse model of Alzheimer's disease","volume":"11","author":"Faivre","year":"2018","journal-title":"Front. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109371_bib76","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s12974-020-02009-7","article-title":"Adenosine A3 receptor as a novel therapeutic target to reduce secondary events and improve neurocognitive functions following traumatic brain injury","volume":"17","author":"Farr","year":"2020","journal-title":"J.\u00a0Neuroinflammation"},{"issue":"9","key":"10.1016\/j.neuropharm.2022.109371_bib77","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0028-3908(97)00137-8","article-title":"ATP-mediated cytotoxicity in microglial cells","volume":"36","author":"Ferrari","year":"1997","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.neuropharm.2022.109371_bib78","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.nlm.2011.08.003","article-title":"The A\u03b2 oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease","volume":"96","author":"Ferreira","year":"2011","journal-title":"Neurobiol. Learn. Mem."},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109371_bib79","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/sj.bjp.0705043","article-title":"Coupling of the nucleotide P2Y4 receptor to neuronal ion channels","volume":"138","author":"Filippov","year":"2003","journal-title":"Br. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.neuropharm.2022.109371_bib80","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s12149-008-0185-5","article-title":"Adenosine A(1) receptors using 8-dicyclopropylmethyl-1-[(11)C]methyl-3-propylxanthine PET in Alzheimer's disease","volume":"22","author":"Fukumitsu","year":"2008","journal-title":"Ann. Nucl. Med."},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109371_bib81","doi-asserted-by":"crossref","DOI":"10.1002\/glia.10248","article-title":"Nucleotide-mediated calcium signaling in rat cortical astrocytes: role of P2X and P2Y receptors","volume":"43","author":"Fumagalli","year":"2003","journal-title":"Glia"},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109371_bib82","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1046\/j.1471-4159.2003.01995.x","article-title":"P2X7 nucleotide receptor activation enhances IFN gamma-induced type II nitric oxide synthase activity in BV-2 microglial cells","volume":"87","author":"Gendron","year":"2003","journal-title":"J.\u00a0Neurochem."},{"issue":"6","key":"10.1016\/j.neuropharm.2022.109371_bib83","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1124\/mol.107.035980","article-title":"Evidence for functional P2X4\/P2X7 heteromeric receptors","volume":"72","author":"Guo","year":"2007","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109371_bib84","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1152\/jn.00675.2016","article-title":"The role of adenosine in the maturation of sleep homeostasis in rats","volume":"117","author":"Gvilia","year":"2017","journal-title":"J.\u00a0Neurophysiol."},{"issue":"1\u20133","key":"10.1016\/j.neuropharm.2022.109371_bib85","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.tox.2011.07.001","article-title":"cAMP production mediated through P2Y(11)-like receptors in rat striatum due to severe, but not moderate, carbon monoxide poisoning","volume":"288","author":"Hara","year":"2011","journal-title":"Toxicology"},{"key":"10.1016\/j.neuropharm.2022.109371_bib86","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fimmu.2013.00085","article-title":"Regulation of inflammation by adenosine","volume":"4","author":"Hask\u00f3","year":"2013","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.neuropharm.2022.109371_bib87","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2174\/187152712803581128","article-title":"P2X1 and P2X2 receptors in the central nervous system as possible drug targets","volume":"11","author":"Hausmann","year":"2012","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"key":"10.1016\/j.neuropharm.2022.109371_bib88","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.conb.2017.02.008","article-title":"Astrocytes and the modulation of sleep","volume":"44","author":"Haydon","year":"2017","journal-title":"Curr. Opin. Neurobiol."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109371_bib89","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12974-017-0904-8","article-title":"The role of microglial P2X7: modulation of cell death and cytokine release","volume":"14","author":"He","year":"2017","journal-title":"J.\u00a0Neuroinflammation"},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109371_bib90","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ajmg.b.30799","article-title":"Association between depression and the Gln460Arg polymorphism of P2RX7 gene: a dimensional approach","volume":"150B","author":"Hejjas","year":"2009","journal-title":"Am. J. Med. Genet. Part B, Neuropsychiatric genetics"},{"issue":"7","key":"10.1016\/j.neuropharm.2022.109371_bib91","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1586\/ern.10.83","article-title":"Sleep deprivation in depression","volume":"10","author":"Hemmeter","year":"2010","journal-title":"Expert Rev. Neurother."},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109371_bib92","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1046\/j.1471-4159.2000.0750965.x","article-title":"Extracellular ATP triggers tumor necrosis factor-alpha release from rat microglia","volume":"75","author":"Hide","year":"2000","journal-title":"J.\u00a0Neurochem."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109371_bib93","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1038\/tp.2012.136","article-title":"Antidepressant effects of sleep deprivation require astrocyte-dependent adenosine mediated signaling","volume":"3","author":"Hines","year":"2013","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109371_bib94","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1124\/jpet.108.149617","volume":"330","author":"Hodgson","year":"2009","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"issue":"6","key":"10.1016\/j.neuropharm.2022.109371_bib95","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1111\/j.1471-4159.2004.02991.x","article-title":"An adenosine A receptor agonist induces sleep by increasing GABA release in the tuberomammillary nucleus to inhibit histaminergic systems in rats","volume":"92","author":"Hong","year":"2005","journal-title":"J.\u00a0Neurochem."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2022.109371_bib96","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0304-3959(02)00032-5","article-title":"Analgesic profile of intrathecal P2X(3) antisense oligonucleotide treatment in chronic inflammatory and neuropathic pain states in rats","volume":"99","author":"Honore","year":"2002","journal-title":"Pain"},{"issue":"10","key":"10.1016\/j.neuropharm.2022.109371_bib97","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/gps.2028","article-title":"A\u00a0predictive depression pattern in mild cognitive impairment","volume":"23","author":"Houde","year":"2008","journal-title":"Int. J. Geriatr. Psychiatr."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109371_bib98","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/002383099300600101","article-title":"Brain oxidative energy and related metabolism, neuronal stress, and Alzheimer's disease: a speculative synthesis","volume":"6","author":"Hoyer","year":"1993","journal-title":"J.\u00a0Geriatr. Psychiatr. Neurol."},{"key":"10.1016\/j.neuropharm.2022.109371_bib99","article-title":"Glial purinergic signaling-mediated oxidative stress (GPOS) in neuropsychiatric disorders","volume":"2022","author":"Huang","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109371_bib100","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41392-021-00553-z","article-title":"From purines to purinergic signalling: molecular functions and human diseases","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109371_bib101","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0898-6568(01)00230-3","article-title":"The P2X(7) receptor-mediated phospholipase D activation is regulated by both PKC-dependent and PKC-independent pathways in a rat brain-derived Type-2 astrocyte cell line, RBA-2","volume":"14","author":"Hung","year":"2002","journal-title":"Cell. Signal."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2022.109371_bib102","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0006-8993(93)90211-5","article-title":"Differential alterations in adenosine A1 and kappa 1 opioid receptors in the striatum in Alzheimer's disease","volume":"616","author":"Ikeda","year":"1993","journal-title":"Brain Res."},{"issue":"30","key":"10.1016\/j.neuropharm.2022.109371_bib103","doi-asserted-by":"crossref","first-page":"7049","DOI":"10.1523\/JNEUROSCI.3103-16.2017","article-title":"Neuronal P2X7 receptors revisited: do they really exist?","volume":"37","author":"Illes","year":"2017","journal-title":"J.\u00a0Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109371_bib104","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/14728222.2019.1575811","article-title":"The P2X7 receptor: a new therapeutic target in Alzheimer's disease","volume":"23","author":"Illes","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.neuropharm.2022.109371_bib105","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neuropharm.2015.08.005","article-title":"Purinergic neurone-glia signalling in cognitive-related pathologies","volume":"104","author":"Illes","year":"2016","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.neuropharm.2022.109371_bib106","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1177\/1073858411418524","article-title":"P2X receptors and their roles in astroglia in the central and peripheral nervous system","volume":"18","author":"Illes","year":"2012","journal-title":"Neuroscientist"},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109371_bib107","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4161\/cam.1.3.4937","article-title":"UDP facilitates microglial phagocytosis through P2Y6 receptors","volume":"1","author":"Inoue","year":"2007","journal-title":"Cell Adhes. Migrat."},{"key":"10.1016\/j.neuropharm.2022.109371_bib108","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0074-7742(09)85012-5","article-title":"P2Y(6)-Evoked microglial phagocytosis","volume":"85","author":"Inoue","year":"2009","journal-title":"Int. Rev. Neurobiol."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109371_bib109","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.biopsych.2015.11.026","article-title":"Psychological stress activates the inflammasome via release of adenosine triphosphate and stimulation of the purinergic type 2X7 receptor","volume":"80","author":"Iwata","year":"2016","journal-title":"Biol. Psychiatr."},{"issue":"12","key":"10.1016\/j.neuropharm.2022.109371_bib110","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1523\/JNEUROSCI.21-12-04134.2001","article-title":"Extracellular nucleotides differentially regulate interleukin-1beta signaling in primary human astrocytes: implications for inflammatory gene expression","volume":"21","author":"John","year":"2001","journal-title":"J.\u00a0Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109371_bib111","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrneurol.2013.269","article-title":"Sleep and Alzheimer disease pathology--a bidirectional relationship","volume":"10","author":"Ju","year":"2014","journal-title":"Nat. Rev. Neurol."},{"issue":"9","key":"10.1016\/j.neuropharm.2022.109371_bib112","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1523\/JNEUROSCI.6357-11.2012","article-title":"Astrocyte-originated ATP protects A\u03b2(1-42)-induced impairment of synaptic plasticity","volume":"32","author":"Jung","year":"2012","journal-title":"J.\u00a0Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109371_bib113","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0304-3940(90)90641-L","article-title":"Hippocampal adenosine A1 receptors are decreased in Alzheimer's disease","volume":"118","author":"Kalaria","year":"1990","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2022.109371_bib114","doi-asserted-by":"crossref","first-page":"h369","DOI":"10.1136\/bmj.h369","article-title":"Assessment and management of behavioral and psychological symptoms of dementia","volume":"350","author":"Kales","year":"2015","journal-title":"BMJ"},{"issue":"25","key":"10.1016\/j.neuropharm.2022.109371_bib115","doi-asserted-by":"crossref","first-page":"7833","DOI":"10.1073\/pnas.1423088112","article-title":"Caffeine acts through neuronal adenosine A2A receptors to prevent mood and memory dysfunction triggered by chronic stress","volume":"112","author":"Kaster","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"7102","key":"10.1016\/j.neuropharm.2022.109371_bib116","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nature04886","article-title":"P2X receptors as cell-surface ATP sensors in health and disease","volume":"442","author":"Khakh","year":"2006","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.neuropharm.2022.109371_bib117","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/j.1471-4159.2009.06048.x","article-title":"Interleukin-1beta enhances nucleotide-induced and alpha-secretase-dependent amyloid precursor protein processing in rat primary cortical neurons via up-regulation of the P2Y(2) receptor","volume":"109","author":"Kong","year":"2009","journal-title":"J.\u00a0Neurochem."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109371_bib118","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4049\/jimmunol.1101224","article-title":"Adenosine augments IL-10 production by microglial cells through an A2B adenosine receptor-mediated process","volume":"188","author":"Koscs\u00f3","year":"2012","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neuropharm.2022.109371_bib119","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbr.2016.10.015","article-title":"Sleep-wakefulness cycle and behavior in pannexin1 knockout mice","volume":"318","author":"Kovalzon","year":"2017","journal-title":"Behav. Brain Res."},{"issue":"12","key":"10.1016\/j.neuropharm.2022.109371_bib120","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/nrn2521","article-title":"Sleep as a fundamental property of neuronal assemblies","volume":"9","author":"Krueger","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"issue":"5","key":"10.1016\/j.neuropharm.2022.109371_bib121","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1152\/japplphysiol.00586.2010","article-title":"ATP and the purine type 2 X7 receptor affect sleep","volume":"109","author":"Krueger","year":"2010","journal-title":"J.\u00a0Appl. Physiol."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109371_bib122","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/mp.2014.151","article-title":"A2A adenosine receptor deletion is protective in a mouse model of Tauopathy","volume":"21","author":"Laurent","year":"2016","journal-title":"Mol. Psychiatr."},{"issue":"9","key":"10.1016\/j.neuropharm.2022.109371_bib123","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.biopsych.2011.12.024","article-title":"Depressive symptoms in mild cognitive impairment predict greater atrophy in Alzheimer's disease-related regions","volume":"71","author":"Lee","year":"2012","journal-title":"Biol. Psychiatr."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109371_bib124","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3858\/emm.2011.43.1.001","article-title":"Microglial P2X\u2087 receptor expression is accompanied by neuronal damage in the cerebral cortex of the APPswe\/PS1dE9 mouse model of Alzheimer's disease","volume":"43","author":"Lee","year":"2011","journal-title":"Exp. Mol. Med."},{"issue":"4","key":"10.1016\/j.neuropharm.2022.109371_bib125","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1007\/s11239-020-02098-4","article-title":"The role of P2Y12 receptor inhibition in ischemic stroke on microglia, platelets and vascular smooth muscle cells","volume":"50","author":"Li","year":"2020","journal-title":"J.\u00a0Thromb. Thrombolysis"},{"issue":"21","key":"10.1016\/j.neuropharm.2022.109371_bib126","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1128\/MCB.00544-13","article-title":"P2Y4 receptor-mediated pinocytosis contributes to amyloid beta-induced self-uptake by microglia","volume":"33","author":"Li","year":"2013","journal-title":"Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.neuropharm.2022.109371_bib127","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2217\/nmt.14.33","article-title":"The sleep-wake cycle and Alzheimer's disease: what do we know?","volume":"4","author":"Lim","year":"2014","journal-title":"Neurodegener. Dis. Manag."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109371_bib128","first-page":"435","article-title":"Amyloid \u03b2 and tau are involved in sleep disorder in Alzheimer's disease by orexin A and adenosine A(1) receptor","volume":"43","author":"Liu","year":"2019","journal-title":"Int. J. Mol. Med."},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109371_bib129","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00441-017-2634-8","article-title":"Time-of-day-dependent expression of purinergic receptors in mouse suprachiasmatic nucleus","volume":"369","author":"Lommen","year":"2017","journal-title":"Cell Tissue Res."},{"issue":"6","key":"10.1016\/j.neuropharm.2022.109371_bib130","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1152\/jn.1999.82.6.3196","article-title":"Cross talk between A(1) and A(2A) adenosine receptors in the hippocampus and cortex of young adult and old rats","volume":"82","author":"Lopes","year":"1999","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuropharm.2022.109371_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113313","article-title":"Design, synthesis and evaluation of 3-amide-5-aryl benzoic acid derivatives as novel P2Y14R antagonists with potential high efficiency against acute gouty arthritis","volume":"216","author":"Lu","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"16","key":"10.1016\/j.neuropharm.2022.109371_bib132","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1093\/hmg\/ddl166","article-title":"P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder","volume":"15","author":"Lucae","year":"2006","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.neuropharm.2022.109371_bib133","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3109\/15622975.2013.795243","article-title":"Coffee, caffeine, and risk of completed suicide: results from three prospective cohorts of American adults","volume":"15","author":"Lucas","year":"2014","journal-title":"World J. Biol. Psychiatr."},{"issue":"5","key":"10.1016\/j.neuropharm.2022.109371_bib134","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jalz.2011.05.2410","article-title":"Neuropsychiatric symptoms in Alzheimer's disease","volume":"7","author":"Lyketsos","year":"2011","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.neuropharm.2022.109371_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2019.109776","article-title":"Caffeine prevents neurodegeneration and behavioral alterations in a mice model of agitated depression","volume":"98","author":"Machado","year":"2020","journal-title":"Progress in neuro-psychopharmacology & biological psychiatry"},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109371_bib136","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.neuron.2017.12.002","article-title":"Microglial ramification, surveillance, and interleukin-1\u03b2 release are regulated by the two-pore domain K+ channel THIK-1","volume":"97","author":"Madry","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2022.109371_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101544","article-title":"Biomarkers used in Alzheimer's disease diagnosis, treatment, and prevention","volume":"74","author":"Mahaman","year":"2022","journal-title":"Ageing Res. Rev."},{"issue":"23","key":"10.1016\/j.neuropharm.2022.109371_bib138","doi-asserted-by":"crossref","first-page":"8342","DOI":"10.1523\/JNEUROSCI.6537-10.2011","article-title":"Circadian regulation of ATP release in astrocytes","volume":"31","author":"Marpegan","year":"2011","journal-title":"J.\u00a0Neurosci."},{"issue":"Suppl.\u00a02","key":"10.1016\/j.neuropharm.2022.109371_bib139","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3233\/JAD-2011-110032","article-title":"Modulating Alzheimer's disease through caffeine: a putative link to epigenetics","volume":"24","author":"Marques","year":"2011","journal-title":"J.\u00a0Alzheim. Dis."},{"issue":"6012","key":"10.1016\/j.neuropharm.2022.109371_bib140","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS beta-amyloid in Alzheimer's disease","volume":"330","author":"Mawuenyega","year":"2010","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109371_bib141","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1023\/A:1027325304203","article-title":"Degradation of Alzheimer's beta-amyloid protein by human and rat brain peptidases: involvement of insulin-degrading enzyme","volume":"22","author":"McDermott","year":"1997","journal-title":"Neurochem. Res."},{"issue":"11","key":"10.1016\/j.neuropharm.2022.109371_bib142","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1097\/01.jnen.0000240470.97295.d3","article-title":"Upregulated expression of purinergic P2X(7) receptor in Alzheimer disease and amyloid-beta peptide-treated microglia and in peptide-injected rat hippocampus","volume":"65","author":"McLarnon","year":"2006","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"issue":"6","key":"10.1016\/j.neuropharm.2022.109371_bib143","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/mp.2008.6","article-title":"Case-control studies show that a non-conservative amino-acid change from a glutamine to arginine in the P2RX7 purinergic receptor protein is associated with both bipolar- and unipolar-affective disorders","volume":"14","author":"McQuillin","year":"2009","journal-title":"Mol. Psychiatr."},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109371_bib144","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3233\/JAD-201437","article-title":"Upregulation of cortical A2A adenosine receptors is reflected in platelets of patients with Alzheimer's disease","volume":"80","author":"Merighi","year":"2021","journal-title":"J\u00a0Alzheimers Dis"},{"issue":"5","key":"10.1016\/j.neuropharm.2022.109371_bib145","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3390\/cells10051267","article-title":"Alzheimer and purinergic signaling: just a matter of inflammation?","volume":"10","author":"Merighi","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.neuropharm.2022.109371_bib146","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/jnr.20314","article-title":"Ageing-related decline in adenosine A1 receptor binding in the rat brain: an autoradiographic study","volume":"78","author":"Meerlo","year":"2004","journal-title":"J.\u00a0Neurosci. Res."},{"issue":"48","key":"10.1016\/j.neuropharm.2022.109371_bib147","doi-asserted-by":"crossref","first-page":"11688","DOI":"10.1523\/JNEUROSCI.3487-16.2017","article-title":"Heterozygosity for the mood disorder-associated variant Gln460Arg Alters P2X7 receptor function and sleep quality","volume":"37","author":"Metzger","year":"2017","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109371_bib148","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.bbr.2015.02.032","article-title":"Adenosine signaling in reserpine-induced depression in rats","volume":"286","author":"Minor","year":"2015","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109371_bib149","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1037\/0735-7044.108.2.265","article-title":"Stress and adenosine: II. Adenosine analogs mimic the effect of inescapable shock on shuttle-escape performance in rats","volume":"108","author":"Minor","year":"1994","journal-title":"Behav. Neurosci."},{"issue":"6","key":"10.1016\/j.neuropharm.2022.109371_bib150","doi-asserted-by":"crossref","first-page":"843","DOI":"10.4088\/JCP.11m07139","article-title":"Bioavailability of S-adenosyl methionine and impact on response in a randomized, double-blind, placebo-controlled trial in major depressive disorder","volume":"73","author":"Mischoulon","year":"2012","journal-title":"J.\u00a0Clin. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109371_bib151","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3389\/fphar.2017.00903","article-title":"Age-related decrease in male extra-striatal adenosine A1 receptors measured Using11C-MPDX PET","volume":"8","author":"Mishina","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.neuropharm.2022.109371_bib152","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.biocel.2010.06.021","article-title":"Microglia: proliferation and activation driven by the P2X7 receptor","volume":"42","author":"Monif","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1\u20133","key":"10.1016\/j.neuropharm.2022.109371_bib153","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0167-4781(01)00291-3","article-title":"Expression pattern of human P2Y receptor subtypes: a quantitative reverse transcription-polymerase chain reaction study","volume":"1521","author":"Moore","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2022.109371_bib154","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0169-328X(03)00330-9","article-title":"GPR105, a novel Gi\/o-coupled UDP-glucose receptor expressed on brain glia and peripheral immune cells, is regulated by immunologic challenge: possible role in neuroimmune function","volume":"118","author":"Moore","year":"2003","journal-title":"Mol. Brain Res."},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109371_bib155","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/(SICI)1096-9861(20000605)421:3<374::AID-CNE6>3.0.CO;2-Z","article-title":"Regional and cellular distribution of the P2Y(1) purinergic receptor in the human brain: striking neuronal localisation","volume":"421","author":"Moore","year":"2000","journal-title":"J.\u00a0Comp. Neurol."},{"issue":"8","key":"10.1016\/j.neuropharm.2022.109371_bib156","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/j.pnpbp.2008.08.021","article-title":"P2RX7 Gln460Arg polymorphism is associated with depression among diabetic patients","volume":"32","author":"Nagy","year":"2008","journal-title":"Progress in neuro-psychopharmacology & biological psychiatry"},{"issue":"7","key":"10.1016\/j.neuropharm.2022.109371_bib157","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/j.1530-0277.2011.01722.x","article-title":"Adenosine and glutamate signaling in neuron-glial interactions: implications in alcoholism and sleep disorders","volume":"36","author":"Nam","year":"2012","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109371_bib158","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/glia.20110","article-title":"The cytokine IL-1beta transiently enhances P2X7 receptor expression and function in human astrocytes","volume":"49","author":"Narcisse","year":"2005","journal-title":"Glia"},{"issue":"4\u20135","key":"10.1016\/j.neuropharm.2022.109371_bib159","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s002100000311","article-title":"Neuronal P2X receptors: localisation and functional properties","volume":"362","author":"N\u00f6renberg","year":"2000","journal-title":"N.\u00a0Schmied. Arch. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109371_bib160","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0304-3940(00)01478-6","article-title":"Expression of inducible nitric oxide synthase mRNA and production of nitric oxide are induced by adenosine triphosphate in cultured rat microglia","volume":"293","author":"Ohtani","year":"2000","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109371_bib161","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11302-018-9635-2","article-title":"Impact of genetic variations in ADORA2A gene on depression and symptoms: a cross-sectional population-based study","volume":"15","author":"Oliveira","year":"2019","journal-title":"Purinergic Signal."},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109371_bib162","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nn.3930","article-title":"Astrocytic adenosine receptor A2A and Gs-coupled signaling regulate memory","volume":"18","author":"Orr","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109371_bib163","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.nbd.2017.10.014","article-title":"Istradefylline reduces memory deficits in aging mice with amyloid pathology","volume":"110","author":"Orr","year":"2018","journal-title":"Neurobiol. Dis."},{"issue":"10","key":"10.1016\/j.neuropharm.2022.109371_bib164","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/ijnp\/pyx046","article-title":"P2X7 receptors drive spine synapse plasticity in the learned helplessness model of depression","volume":"20","author":"Otrokocsi","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"5","key":"10.1016\/j.neuropharm.2022.109371_bib165","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.952","article-title":"Behavioral changes induced through adenosine A2A receptor ligands in a rat depression model induced by olfactory bulbectomy","volume":"8","author":"Padilla","year":"2018","journal-title":"Brain and behavior"},{"issue":"12","key":"10.1016\/j.neuropharm.2022.109371_bib166","doi-asserted-by":"crossref","DOI":"10.1172\/JCI149371","article-title":"Caffeine intake exerts dual genome-wide effects on hippocampal metabolism and learning-dependent transcription","volume":"132","author":"Paiva","year":"2022","journal-title":"J.\u00a0Clin. Invest."},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109371_bib167","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/JGP.0b013e3181b0fa13","article-title":"Late-life depression, mild cognitive impairment, and dementia: possible continuum?","volume":"18","author":"Panza","year":"2010","journal-title":"Am. J. Geriatr. Psychiatr.: official journal of the American. Association for Geriatric Psychiatry"},{"issue":"8","key":"10.1016\/j.neuropharm.2022.109371_bib168","doi-asserted-by":"crossref","first-page":"948","DOI":"10.2174\/156802611795347582","article-title":"Molecular biology of nucleoside transporters and their distributions and functions in the brain","volume":"11","author":"Parkinson","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"issue":"15","key":"10.1016\/j.neuropharm.2022.109371_bib169","doi-asserted-by":"crossref","first-page":"13309","DOI":"10.1074\/jbc.M209478200","article-title":"P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease","volume":"278","author":"Parvathenani","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2022.109371_bib170","first-page":"1","article-title":"World Alzheimer report 2018: the state of the Art of dementia research: new frontiers","volume":"1","author":"Patterson","year":"2018","journal-title":"Alzheimer\u2019s Disease International"},{"issue":"6508","key":"10.1016\/j.neuropharm.2022.109371_bib171","doi-asserted-by":"crossref","DOI":"10.1126\/science.abb0556","article-title":"Regulation of sleep homeostasis mediator adenosine by basal forebrain glutamatergic neurons","volume":"369","author":"Peng","year":"2020","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.neuropharm.2022.109371_bib172","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.euroneuro.2013.01.008","article-title":"Antidepressant- and anticompulsive-like effects of purinergic receptor blockade: involvement of nitric oxide","volume":"23","author":"Pereira","year":"2013","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.neuropharm.2022.109371_bib173","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.csbj.2015.02.002","article-title":"Neuroprotection mediated by P2Y13 nucleotide receptors in neurons","volume":"13","author":"P\u00e9rez-Sen","year":"2015","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.neuropharm.2022.109371_bib174","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.smrv.2014.03.007","article-title":"Sleep and Alzheimer's disease","volume":"19","author":"Peter-Derex","year":"2015","journal-title":"Sleep Med. Rev."},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109371_bib175","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s12640-018-9959-2","article-title":"Antidepressant-like activity of typical antidepressant drugs in the forced swim test and tail suspension test in mice is augmented by DMPX, an adenosine A2A receptor antagonist","volume":"35","author":"Poleszak","year":"2019","journal-title":"Neurotox. Res."},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109371_bib176","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0306-4522(00)00220-7","article-title":"Brain site-specificity of extracellular adenosine concentration changes during sleep deprivation and spontaneous sleep: an in\u00a0vivo microdialysis study","volume":"99","author":"Porkka-Heiskanen","year":"2000","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.neuropharm.2022.109371_bib177","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.freeradbiomed.2010.07.007","article-title":"Caffeine protects against oxidative stress and Alzheimer's disease-like pathology in rabbit hippocampus induced by cholesterol-enriched diet","volume":"49","author":"Prasanthi","year":"2010","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.neuropharm.2022.109371_bib178","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/S0306-4522(96)00637-9","article-title":"Release of ATP from cultured rat astrocytes elicited by glutamate receptor activation","volume":"78","author":"Queiroz","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2022.109371_bib179","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12974-014-0141-3","article-title":"Microglia P2Y\u2086 receptors mediate nitric oxide release and astrocyte apoptosis","volume":"11","author":"Quintas","year":"2014","journal-title":"J.\u00a0Neuroinflammation"},{"issue":"4","key":"10.1016\/j.neuropharm.2022.109371_bib180","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.neuropharm.2007.06.010","article-title":"Differential regulation of microglial P2X4 and P2X7 ATP receptors following LPS-induced activation","volume":"53","author":"Raouf","year":"2007","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.neuropharm.2022.109371_bib181","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1176\/appi.ajp.158.12.2048","article-title":"Multinuclear magnetic resonance spectroscopy studies of brain purines in major depression","volume":"158","author":"Renshaw","year":"2001","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109371_bib182","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.7834","article-title":"Reduced P2X receptor levels are associated with antidepressant effect in the learned helplessness model","volume":"7","author":"Ribeiro","year":"2019","journal-title":"PeerJ"},{"issue":"11","key":"10.1016\/j.neuropharm.2022.109371_bib183","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1177\/0269881119872173","article-title":"Antidepressant-like effect induced by P2X7 receptor blockade in FSL rats is associated with BDNF signalling activation","volume":"33","author":"Ribeiro","year":"2019","journal-title":"J.\u00a0Psychopharmacol."},{"issue":"27","key":"10.1016\/j.neuropharm.2022.109371_bib184","doi-asserted-by":"crossref","first-page":"6286","DOI":"10.1523\/JNEUROSCI.0628-05.2005","article-title":"Dual presynaptic control by ATP of glutamate release via facilitatory P2X1, P2X2\/3, and P2X3 and inhibitory P2Y1, P2Y2, and\/or P2Y4 receptors in the rat hippocampus","volume":"25","author":"Rodrigues","year":"2005","journal-title":"J.\u00a0Neurosci.: the official journal of the Society for Neuroscience"},{"key":"10.1016\/j.neuropharm.2022.109371_bib185","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.semcdb.2018.12.001","article-title":"Purinergic signalling and brain development","volume":"95","author":"Rodrigues","year":"2019","journal-title":"Semin. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.neuropharm.2022.109371_bib186","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jpsychires.2009.10.005","article-title":"Single nucleotide polymorphisms that were identified in affective mood disorders affect ATP-activated P2X7 receptor functions","volume":"44","author":"Roger","year":"2010","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2022.109371_bib187","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fimmu.2020.00113","article-title":"Evolutionary origin of the P2X7 C-ter region: capture of an Ancient ballast domain by a P2X4-like gene in Ancient jawed vertebrates","volume":"11","author":"Rump","year":"2020","journal-title":"Front. Immunol."},{"issue":"17","key":"10.1016\/j.neuropharm.2022.109371_bib188","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1097\/WNR.0b013e3283179333","article-title":"Block of purinergic P2X(7) receptor is neuroprotective in an animal model of Alzheimer's disease","volume":"19","author":"Ryu","year":"2008","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2022.109371_bib189","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.neuropharm.2017.10.027","article-title":"P2X receptor overexpression induced by soluble oligomers of amyloid beta peptide potentiates synaptic failure and neuronal dyshomeostasis in cellular models of Alzheimer's disease","volume":"128","author":"S\u00e1ez-Orellana","year":"2018","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109371_bib190","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00232-001-0116-z","article-title":"Immunolocalization of P2Y4 and P2Y2 purinergic receptors in strial marginal cells and vestibular dark cells","volume":"185","author":"Sage","year":"2002","journal-title":"J.\u00a0Membr. Biol."},{"issue":"7","key":"10.1016\/j.neuropharm.2022.109371_bib191","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.3390\/cells9071628","article-title":"Adenosine and metabotropic glutamate receptors are present in blood serum and exosomes from SAMP8 mice: modulation by aging and resveratrol","volume":"9","author":"S\u00e1nchez-Melgar","year":"2020","journal-title":"Cells"},{"issue":"19","key":"10.1016\/j.neuropharm.2022.109371_bib192","doi-asserted-by":"crossref","first-page":"7300","DOI":"10.3390\/ijms21197300","article-title":"Adenosine metabolism in the cerebral cortex from several mice models during aging","volume":"21","author":"S\u00e1nchez-Melgar","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.neuropharm.2022.109371_bib193","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.4049\/jimmunol.0803612","article-title":"Activation of microglia by amyloid {beta} requires P2X7 receptor expression","volume":"182","author":"Sanz","year":"2009","journal-title":"J.\u00a0Immunol."},{"issue":"9","key":"10.1016\/j.neuropharm.2022.109371_bib194","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.4049\/jimmunol.164.9.4893","article-title":"Kinetics and mechanism of ATP-dependent IL-1 beta release from microglial cells","volume":"164","author":"Sanz","year":"2000","journal-title":"J.\u00a0Immunol."},{"issue":"s1","key":"10.1016\/j.neuropharm.2022.109371_bib195","doi-asserted-by":"crossref","first-page":"S313","DOI":"10.3233\/JAD-179925","article-title":"Brain inflammation connects cognitive and non-cognitive symptoms in Alzheimer's disease","volume":"64","author":"Selles","year":"2018","journal-title":"J\u00a0Alzheimers Dis"},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109371_bib196","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.neuron.2015.07.010","article-title":"Increased signaling via adenosine A1 receptors, sleep deprivation, imipramine, and ketamine inhibit depressive-like behavior via induction of Homer1a","volume":"87","author":"Serchov","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2022.109371_bib197","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107834","article-title":"Enhanced adenosine A1 receptor and Homer1a expression in hippocampus modulates the resilience to stress-induced depression-like behavior","volume":"162","author":"Serchov","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109371_bib198","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1742-2094-5-7","article-title":"The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective","volume":"5","author":"Shaftel","year":"2008","journal-title":"J.\u00a0Neuroinflammation"},{"issue":"5","key":"10.1016\/j.neuropharm.2022.109371_bib199","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1530-0277.2010.01153.x","article-title":"Effects of ethanol on extracellular levels of adenosine in the basal forebrain: an in\u00a0vivo microdialysis study in freely behaving rats","volume":"34","author":"Sharma","year":"2010","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109371_bib200","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1471-4159.2010.06980.x","article-title":"Role of adenosine and wake-promoting basal forebrain in insomnia and associated sleep disruptions caused by ethanol dependence","volume":"115","author":"Sharma","year":"2010","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2022.109371_bib201","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.smrv.2017.06.010","article-title":"Sleep disturbances increase the risk of dementia: a systematic review and meta-analysis","volume":"40","author":"Shi","year":"2018","journal-title":"Sleep Med. Rev."},{"key":"10.1016\/j.neuropharm.2022.109371_bib202","article-title":"Early synaptic deficits in the APP\/PS1 mouse model of Alzheimer's disease involve neuronal adenosine A2A receptors","volume":"7","author":"Silva","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2022.109371_bib50","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.nbd.2018.05.024","article-title":"Blockade of adenosine A2A receptors recovers early deficits of memory and plasticity in the triple transgenic mouse model of Alzheimer's disease","volume":"117","author":"Silva","year":"2018","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.neuropharm.2022.109371_bib203","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1471-4159.1983.tb00829.x","article-title":"Metabolic processes in Alzheimer's disease: adenine nucleotide content and production of 14CO2 from [U-14C]glucose in\u00a0vitro in human neocortex","volume":"41","author":"Sims","year":"1983","journal-title":"J.\u00a0Neurochem."},{"issue":"6482","key":"10.1016\/j.neuropharm.2022.109371_bib204","doi-asserted-by":"crossref","DOI":"10.1126\/science.aay5947","article-title":"An atlas of the protein-coding genes in the human, pig, and mouse brain","volume":"367","author":"Sj\u00f6stedt","year":"2020","journal-title":"Science"},{"issue":"15","key":"10.1016\/j.neuropharm.2022.109371_bib205","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.jpsychires.2010.04.013","article-title":"Functional significance of P2RX7 polymorphisms associated with affective mood disorders","volume":"44","author":"Sluyter","year":"2010","journal-title":"J.\u00a0Psychiatr. Res."},{"issue":"4","key":"10.1016\/j.neuropharm.2022.109371_bib206","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/ajmg.b.31179","article-title":"P2RX7 gene is associated consistently with mood disorders and predicts clinical outcome in three clinical cohorts","volume":"156B","author":"Soronen","year":"2011","journal-title":"Am. J. Med. Genet. Part B, Neuropsychiatric genetics"},{"issue":"10","key":"10.1016\/j.neuropharm.2022.109371_bib207","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.tips.2014.08.002","article-title":"P2X7 receptor: an emerging target in central nervous system diseases","volume":"35","author":"Sperl\u00e1gh","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.neuropharm.2022.109371_bib208","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3390\/molecules22040676","article-title":"Adenosine A1 and A2A receptors in the brain: current research and their role in neurodegeneration","volume":"22","author":"Stockwell","year":"2017","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.neuropharm.2022.109371_bib209","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1007\/s11064-022-03578-0","article-title":"Sleep disturbance and Alzheimer's disease: the glial connection","volume":"47","author":"Sunkaria","year":"2022","journal-title":"Neurochem. Res."},{"issue":"5","key":"10.1016\/j.neuropharm.2022.109371_bib210","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bj.2017.06.010","article-title":"P2X4: a fast and sensitive purinergic receptor","volume":"40","author":"Suurv\u00e4li","year":"2017","journal-title":"Biomed. J."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109371_bib211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1523\/JNEUROSCI.3792-03.2004","article-title":"Production and release of neuroprotective tumor necrosis factor by P2X7 receptor-activated microglia","volume":"24","author":"Suzuki","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109371_bib212","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3389\/fphar.2018.00192","article-title":"Circadian ATP release in organotypic cultures of the rat suprachiasmatic nucleus is dependent on P2X7 and P2Y receptors","volume":"9","author":"Svobodova","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109371_bib213","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1089\/caff.2019.0020","article-title":"Prevalence and correlates of caffeine use disorder symptoms among a United States sample","volume":"10","author":"Sweeney","year":"2020","journal-title":"Journal of caffeine and adenosine research"},{"issue":"4","key":"10.1016\/j.neuropharm.2022.109371_bib214","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.pharep.2019.03.007","article-title":"Agomelatine and tianeptine antidepressant activity in mice behavioral despair tests is enhanced by DMPX, a selective adenosine A2A receptor antagonist, but not DPCPX, a selective adenosine A1 receptor antagonist","volume":"71","author":"Szopa","year":"2019","journal-title":"Pharmacol. Rep."},{"issue":"9","key":"10.1016\/j.neuropharm.2022.109371_bib215","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11920-022-01347-y","article-title":"Managing behavioral and psychological symptoms of dementia (BPSD) in the era of boxed warnings","volume":"24","author":"Tampi","year":"2022","journal-title":"Curr. Psychiatr. Rep."},{"issue":"8","key":"10.1016\/j.neuropharm.2022.109371_bib216","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1038\/s41380-018-0110-9","article-title":"Age-related shift in LTD is dependent on neuronal adenosine A2A receptors interplay with mGluR5 and NMDA receptors","volume":"25","author":"Temido-Ferreira","year":"2020","journal-title":"Mol. Psychiatr."},{"issue":"10","key":"10.1016\/j.neuropharm.2022.109371_bib217","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1523\/JNEUROSCI.23-10-04278.2003","article-title":"A1 receptor and adenosinergic homeostatic regulation of sleep-wakefulness: effects of antisense to the A1 receptor in the cholinergic basal forebrain","volume":"23","author":"Thakkar","year":"2003","journal-title":"J.\u00a0Neurosci."},{"issue":"19","key":"10.1016\/j.neuropharm.2022.109371_bib218","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.1523\/JNEUROSCI.0323-08.2008","article-title":"P2Y12 receptors in spinal microglia are required for neuropathic pain after peripheral nerve injury","volume":"28","author":"Tozaki-Saitoh","year":"2008","journal-title":"J.\u00a0Neurosci.: the official journal of the Society for Neuroscience"},{"issue":"4","key":"10.1016\/j.neuropharm.2022.109371_bib219","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0306-4522(93)90533-L","article-title":"Reduced density of adenosine A1 receptors and preserved coupling of adenosine A1 receptors to G proteins in Alzheimer hippocampus: a quantitative autoradiographic study","volume":"52","author":"U\u0142as","year":"1993","journal-title":"Neuroscience"},{"issue":"10","key":"10.1016\/j.neuropharm.2022.109371_bib220","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s11064-005-8792-1","article-title":"The role of glial adenosine receptors in neural resilience and the neurobiology of mood disorders","volume":"30","author":"Van-Calker","year":"2005","journal-title":"Neurochem. Res."},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109371_bib221","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12017-009-8073-2","article-title":"Amyloid-beta induces a caspase-mediated cleavage of P2X4 to promote purinotoxicity","volume":"11","author":"Varma","year":"2009","journal-title":"NeuroMolecular Med."},{"issue":"6","key":"10.1016\/j.neuropharm.2022.109371_bib222","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/1568007033482643","article-title":"Extracellular ATP and neurodegeneration","volume":"2","author":"Volont\u00e9","year":"2003","journal-title":"Curr. Drug Targets - CNS Neurol. Disord."},{"issue":"6","key":"10.1016\/j.neuropharm.2022.109371_bib223","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2174\/187152712803581137","article-title":"P2X7 receptors: channels, pores and more","volume":"11","author":"Volont\u00e9","year":"2012","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109371_bib224","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/glia.10004","article-title":"Activation of P2X(7) receptors induced [(3)H]GABA release from the RBA-2 type-2 astrocyte cell line through a Cl(-)\/HCO(3)(-)-dependent mechanism","volume":"37","author":"Wang","year":"2002","journal-title":"Glia"},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109371_bib225","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1177\/0004867415603131","article-title":"Coffee and caffeine consumption and depression: a meta-analysis of observational studies","volume":"50","author":"Wang","year":"2016","journal-title":"Aust. N. Z. J. Psychiatr."},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109371_bib226","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s11302-012-9307-6","article-title":"Neuroprotective roles of the P2Y(2) receptor","volume":"8","author":"Weisman","year":"2012","journal-title":"Purinergic Signal."},{"issue":"1\u20133","key":"10.1016\/j.neuropharm.2022.109371_bib227","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1385\/MN:31:1-3:169","article-title":"Molecular determinants of P2Y2 nucleotide receptor function: implications for proliferative and inflammatory pathways in astrocytes","volume":"31","author":"Weisman","year":"2005","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.neuropharm.2022.109371_bib228","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/WAD.0b013e3181e30846","article-title":"Sleep influences the severity of memory disruption in amnestic mild cognitive impairment: results from sleep self-assessment and continuous activity monitoring","volume":"24","author":"Westerberg","year":"2010","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.neuropharm.2022.109371_bib229","series-title":"Dementia","author":"WHO","year":"2017"},{"key":"10.1016\/j.neuropharm.2022.109371_bib230","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neuropharm.2015.10.031","article-title":"Purinergic receptors as potential therapeutic targets in Alzheimer's disease","volume":"104","author":"Woods","year":"2016","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109371_bib231","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1037\/0735-7044.112.2.399","article-title":"Inhibition of adenosine deaminase by erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA) mimics the effect of inescapable shock on escape learning in rats","volume":"112","author":"Woodson","year":"1998","journal-title":"Behav. Neurosci."},{"issue":"4","key":"10.1016\/j.neuropharm.2022.109371_bib232","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.4049\/jimmunol.1103207","article-title":"GPR105 ablation prevents inflammation and improves insulin sensitivity in mice with diet-induced obesity","volume":"189","author":"Xu","year":"2012","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neuropharm.2022.109371_bib233","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pbb.2013.10.022","article-title":"Antidepressant-like activity of the adenosine A(2A) receptor antagonist, istradefylline (KW-6002), in the forced swim test and the tail suspension test in rodents","volume":"114\u2013115","author":"Yamada","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109371_bib234","article-title":"Activation of basal forebrain purinergic P2 receptors promotes wakefulness in mice","volume":"8","author":"Yang","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2022.109371_bib235","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.brainres.2007.11.064","article-title":"Cellular localization of P2X7 receptor mRNA in the rat brain","volume":"1194","author":"Yu","year":"2008","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109371_bib236","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12974-017-0865-y","article-title":"Activation of P2X7 receptor and NLRP3 inflammasome assembly in hippocampal glial cells mediates chronic stress-induced depressive-like behaviors","volume":"14","author":"Yue","year":"2017","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2022.109371_bib237","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3389\/fncel.2019.00438","article-title":"Caffeine consumption during pregnancy Accelerates the development of cognitive deficits in offspring in a model of tauopathy","volume":"13","author":"Zappettini","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109371_bib238","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.brainres.2011.08.036","article-title":"Caffeine induces beneficial changes in PKA signaling and JNK and ERK activities in the striatum and cortex of Alzheimer's transgenic mice","volume":"1417","author":"Zeitlin","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109371_bib239","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jad.2022.03.010","article-title":"Systematic evaluation of the associations between mental disorders and dementia: an umbrella review of systematic reviews and meta-analyses","volume":"307","author":"Zhao","year":"2022","journal-title":"J.\u00a0Affect. Disord."},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109371_bib240","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.3390\/ijms23031904","article-title":"High, in contrast to low levels of acute stress induce depressive-like behavior by involving astrocytic, in addition to microglial P2X7 receptors in the rodent Hippocampus","volume":"23","author":"Zhao","year":"2022","journal-title":"Int. J. Mol. Sci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822004300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822004300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:23:29Z","timestamp":1758439409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390822004300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":240,"alternative-id":["S0028390822004300"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109371","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Purinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109371","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109371"}}